Disparity In Breast Cancer Population Is Challenge For FDA: Can Genetic Testing Help?
Executive Summary
Breast cancer meeting highlights challenges of patient-focused drug development as breast cancer patients ask for trials to better identify characteristics of super-responders so patients can make more informed risk-benefit decisions.